Outlook Therapeutics, Inc. (OTLK)
0.414
-0.02
(-4.12%)
USD |
NASDAQ |
Mar 06, 16:00
0.4141
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Shareholders Equity (Quarterly) : -38.55M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -261.84M |
| Amicus Therapeutics, Inc. | 274.24M |
| CorMedix, Inc. | 405.31M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 18.24M |
| Total Liabilities (Quarterly) | 56.79M |
| Debt to Equity Ratio | -0.957 |
| Current Ratio | 0.3499 |
| Net Debt Paydown Yield | -0.82% |